Loading clinical trials...
Loading clinical trials...
An Open-Label, Chronic Exposure Evaluation of the Safety of CLONICEL (Clonidine HCl Sustained Release) in the Treatment of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions
Interventions
CLONICEL (Clonidine HCl sustained release)
Locations
27
United States
Little Rock, Arkansas, United States
El Centro, California, United States
Irvine, California, United States
San Diego, California, United States
Bradenton, Florida, United States
Gainesville, Florida, United States
Start Date
January 1, 2008
Primary Completion Date
March 1, 2010
Completion Date
June 1, 2010
Last Updated
April 18, 2018
NCT07439276
NCT04631042
NCT06810180
NCT07189442
NCT06325813
NCT05683756
Lead Sponsor
Shionogi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions